BlueCrest Capital Management’s Elevance Health ELV Stock Holding History

BlueCrest Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,574	Closed	-$783K	–	226
2023 Q4	$742K	Buy	+1,574	New	+$728K	0.03%	186
2018 Q4	–	Sell	-3,320	Closed	-$910K	–	1019
2018 Q3	$910K	Buy	3,320 +1,062	+47%	+$276K	0.02%	482
2018 Q2	$537K	Sell	2,258 -2,146	-49%	-$497K	0.01%	797
2018 Q1	$968K	Sell	4,404 -15,582	-78%	-$3.66M	0.03%	492
2017 Q4	$4.5M	Buy	+19,986	New	+$4.26M	0.12%	164
2017 Q3	–	Sell	-4,064	Closed	-$765K	–	905
2017 Q2	$765K	Buy	+4,064	New	+$730K	0.03%	512
2015 Q4	–	Sell	-2,134	Closed	-$299K	–	1023
2015 Q3	$299K	Sell	2,134 -7,979	-79%	-$1.2M	0.01%	704
2015 Q2	$1.66M	Buy	+10,113	New	+$1.62M	0.05%	395
2015 Q1	–	Sell	-3,039	Closed	-$382K	–	649
2014 Q4	$382K	Buy	+3,039	New	+$376K	0.01%	474

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlueCrest Capital Management's ELV Position: Q1 2024 in Review

BlueCrest Capital Management sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 1,574 shares — an estimated $783K sold.

BlueCrest Capital Management first reported a position in ELV in Q4 2014 and held it in 9 quarters. The position peaked at $4.5M in Q4 2017. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

BlueCrest Capital Management reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
BlueCrest Capital Management sold 1,574 Elevance Health shares in Q1 2024, an estimated $783K.
BlueCrest Capital Management first reported a position in Elevance Health in Q4 2014 and held it in 9 quarters.
BlueCrest Capital Management's Elevance Health position peaked at $4.5M in Q4 2017.
1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on BlueCrest Capital Management's 13F filing for Q1 2024, filed 15 May 2024.